Table 1.
Description of the datasets used in this study
| Number | Platforms | #Gene | Control | Case | Control vs. Case | Database |
|---|---|---|---|---|---|---|
| GSE23878 | GPL570a | 20486 | 24 | 35 | Normal vs. COAD | GEO |
| GSE37364 | GPL570 | 20486 | 38 | 27 | Normal vs. COAD | GEO |
| GSE20916 | GPL570 | 20486 | 24 | 45 | Normal vs. COAD | GEO |
| GSE29001 | GPL571b | 12432 | 12 | 12 | Normal vs. ESCC | GEO |
| GSE20347 | GPL571 | 12432 | 17 | 17 | Normal vs. ESCC | GEO |
| GSE38129 | GPL571 | 12432 | 30 | 30 | Normal vs. ESCC | GEO |
| Batch93 | RNASeqV2c | 17618 | 16 | 41 | Normal vs. BRCA | TCGA |
| Batch96 | RNASeqV2 | 17675 | 15 | 41 | Normal vs. BRCA | TCGA |
| Batch109 | RNASeqV2 | 17679 | 15 | 70 | Normal vs. BRCA | TCGA |
| The data of ER positive breast cancer | ||||||
| GSE22093 | GPL96d | 12432 | 10 | 32 | pCR vs. RD | GEO |
| GSE23988 | GPL96 | 12432 | 7 | 24 | pCR vs. RD | GEO |
| GSE42822 | GPL96 | 12432 | 7 | 19 | pCR vs. RD | GEO |
| GSE20271 | GPL96 | 12432 | 6 | 83 | pCR vs. RD | GEO |
| GSE20194T | GPL96 | 12432 | 4 | 61 | pCR vs. RD | GEO |
| The data of ER negative breast cancer | ||||||
| GSE22093 | GPL96 | 12432 | 18 | 37 | pCR vs. RD | GEO |
| GSE23988 | GPL96 | 12432 | 13 | 16 | pCR vs. RD | GEO |
| GSE42822 | GPL96 | 12432 | 13 | 15 | pCR vs. RD | GEO |
| GSE20271 | GPL96 | 12432 | 13 | 50 | pCR vs. RD | GEO |
| GSE20194T | GPL96 | 12432 | 16 | 16 | pCR vs. RD | GEO |
Note: a Affymetrix Human Genome U133 Plus 2.0 Array; b Affymetrix Human Genome U133A 2.0 Array; c UNC IlluminaHiSeq_RNASeqV2; d Affymetrix Human Genome U133A Array Abbreviation: COAD: Colon adenocarcinoma; ESCC: Esophageal squamous cell carcinoma; BRCA, Breast invasive carcinoma; pCR: pathologic complete response; RD, residual disease. GEO: Gene Expression Omnibus; TCGA, The Cancer Genome Atlas.